Perrigo plant workers strike; China's Harbin moves odorous plant;

> About 350 workers at a Perrigo ($PRGO) plant in the Bronx borough of New York City have gone on strike after being locked out after a breakdown in negotiations over a new contract. Story

> A consortium of Hermes Pharma, Research Center Pharmaceutical Engineering GmbH (RCPE), INNOJET Herbert Hüttlin and the Karl Franzens University has been created to develop new formulations and manufacturing processes that can be used to mask bad tastes and odors associated with some APIs. Release

> The FDA announced that as part of the new program to collect user fees from generic drugmakers, it "will aim to achieve risk-adjusted biennial inspections and parity of inspection coverage between foreign and domestic firms in five years." Release

> To aid an expansion in developing countries, Sproxil has nailed down a deal with mobile giant Bharti Airtel that allows it to expand its mobile system for authenticating drugs to 17 countries in Africa where Bharti provides wireless service. Story

> South Carolina-based American BioTech Supply has donated four new vaccine refrigerators to Denver Health, a Colorado safety-net healthcare organization. Item

> Sigma-Aldrich ($SIAL) has an agreement to distribute mass spectrometry-based tagging chemistries from AB SCIEX. Release

And Finally... Chinese drugmaker Harbin Pharmaceutical Group, which has been battling with neighbors about odors from its plant in downtown Harbin, has started construction on a new $110 million plant on the outskirts of town. Story

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.